Dr. Mark Holterman: Saving and Changing Lives

Dr. Mark Holterman is a man with many hats: CEO of Mariam Global Health, pediatric surgeon, researcher, professor, and philanthropist to name a few. All of these diverse roles that Dr. Holterman takes on revolve around his goals of inspiring innovation in the medical field and helping save and change children’s lives through medicine. Learn more about Dr. Mark Holreman at Interview.net.

One way in which Dr. Holterman demonstrates his dedication to the aforementioned goals is through his support, both in time and money, to health-related charities such as the International Pediatric Specialists Alliance for the Children of Vietnam (IPSAC-VN) and Children’s Surgery International (CSI). IPSAC-VN works throughout the nation of Vietnam to train healthcare professionals and surgeons in the latest techniques and advances to benefit children throughout the country. CSI similarly offers care and education to benefit Vietnamese children through the operation of the Blossom House foster home and supporting health care at Provincial Hospital. While Dr. Holterman’s contributions are greatly appreciated, both groups are always in need of volunteer assistance and donations.

Follow: https://twitter.com/MarkHolterman

Another way in which Dr. Mark Holterman strives to help others through medicine is in his role as CEO of Mariam Global Health, a global investment firm. Through Mariam Global Health, Dr. Holterman works to solve health concerns through innovative research and technological development. As an investment firm, they invest capital in health organizations worldwide. They do this by connecting what Dr. Mark Holterman refers to as “Impact Innovators” with “Impact Investors.”

These innovations tend to focus on three particular research areas: stem cell regeneration therapy, cancer treatments, and obesity management. Dr. Holterman also feels that biotechnology, regenerative medicine, and medical photonics are exciting fields of study.

Despite the busy nature of his various enterprises, Dr. Holterman did take the time to expound on areas of personal and professional growth. He takes time out of every day to be thankful for what is happening in his life. It has helped him to swallow his pride and avoid being greedy. Due to that, he finds himself able to ask others, particularly experts, for advice. This, in turn, helps foster his . Learn more on Crunchbase about Dr. Mark Holterman.

Genetic Biomarkers of Lung Cancer and the Importance of Eric Lefkofskys Tempus

It is a known fact that both genetic and environmental risk factors cause lung cancer, and smoking considered as a prime environmental factor for the disease. A recent study conducted by Dartmouth research team displayed that gene-smoking interactions of people are a serious risk factor for developing the lung cancer. The study showed that three novel single-nucleotide polymorphisms (SNPs) or its variations in the human DNA define the lung cancer risks. The team revealed that it used phenotype and genotype data to arrive the conclusions of the study.

They expressed the feeling that Genome-wide interaction scanning is a significant challenge as most of the genome-wide association studies are working around effect association analysis and not looking for interaction analysis. Yafang Li, Ph.D., the team leader of the research team, confirmed that they could only conduct research in a limited Caucasian population due to the limited genotype data available for them. He hopes that in future, the team would get more genotype data that can help them for several ground-breaking observations related to gene-smoking interaction when it comes to lung cancer disease.

This is where the mission of Tempus, a technology firm co-founded by Eric Lefkofsky, exactly fits into the growing treatment and research needs. The company works on individualized treatment plans to fight better against cancer. It adds efficiency to the treatment regime using genomic data. The firm started working towards making largest clinical and molecular data library in the world to help the researchers and physicians to counter cancer effectively.

Eric Lefkofsky is an entrepreneur based in Chicago and known for multiple ventures during his more than two decades of entrepreneurial career. He co-founded Mediaocean, Lightbank, Uptake, InnerWorkings, Groupon, and Echo Global Logistics during the period. Lefkofsky started his entrepreneurial journey from his college days when he started selling carpet.

He is also highly involved in many philanthropic activities and a number of community support initiatives. Lefkofsky serves on the boards of The Museum of Science and Industry, Children’s Memorial Hospital – Chicago, and The Art Institute of Chicago. Additionally, he collaborated with the efforts of bringing the Summer Olympics 2016 to Chicago.

Eric Lefkofsky is also interested in sharing his management lessons and ideas to students of business schools in Chicago. He lectured about disruptive business models at Kellogg School of Management and Kellstadt Graduate School of Business, previously. In 2013, he became part of The Giving Pledge – a noble initiative where its members contribute at least 50% of their lifetime wealth to philanthropy.

His Facebook Page: https://www.facebook.com/eplefkofsky/